Company: INV
Filing Date: 2025-04-23
Form Type: 424B3
Source: 0001628280-25-019356
Chunk: 17

Company: Innventure, Inc.
Filing Date: 2025-04-23
Form: 424B3
Chunk 17
---
 the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

We will remain an emerging growth company until the earlier of (1) December 21, 2026, (2) the last day of the fiscal year (a) in which we have total annual gross revenue of at least $1.235 billion or (b) in which we are deemed to be a large accelerated filer, which means the market value of shares of our Common Stock that are held by non-affiliates exceeds $700.0 million as of the prior June 30, and (3) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.

#### Risk Factors
Our business is subject to numerous risks and uncertainties, including those highlighted in the section titled “ Risk Factors ,” that represent challenges that we face in connection with the successful implementation of our strategy and growth of our business.

#### Corporate Information
The mailing address of our principal executive office is 6900 Tavistock Lakes Blvd, Suite 400, Orlando, Florida 32827, and our telephone number is (321) 209-6787.

<div align='center'>10</div>

THE OFFERING

| Issuer                                                                                                                                        |     | Innventure, Inc.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Shares of Common Stock that may be offered and sold from time to time by the Selling Stockholders named herein or their permitted transferees |     | Up to 14,126,970 shares of Common Stock, which includes (i) up to 3,260,175 shares of Common Stock that may be issued upon conversion of Series B Preferred Stock, (ii) up to 4,209,314 shares of Common Stock that we may issue and sell to Yorkville, from time to time pursuant to the SEPA (without exceeding the Exchange Cap), (iii) 5,657,481 shares of Common Stock held by certain stockholders party to the A&R Registration Rights Agreement, and (iv) 1,000,000 shares of Common Stock that may be issued upon exercise of the WTI Warrants.                         |
| Shares of Common Stock outstanding                                                                                                            |     | 47,106,300 (as of April 11, 2025)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Use of proceeds                                                                                                                               |     | We will not receive any of the proceeds from such sales of the shares of